Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $1.73 billion. The enterprise value is $5.58 billion.
| Market Cap | 1.73B |
| Enterprise Value | 5.58B |
Important Dates
The next estimated earnings date is Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 129.71 million shares outstanding. The number of shares has increased by 1.28% in one year.
| Current Share Class | 129.71M |
| Shares Outstanding | 129.71M |
| Shares Change (YoY) | +1.28% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 1.82% |
| Owned by Institutions (%) | 74.35% |
| Float | 65.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 51.23 |
| PS Ratio | 0.51 |
| Forward PS | 0.59 |
| PB Ratio | 1.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.21 |
| P/OCF Ratio | 6.70 |
| PEG Ratio | 3.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.63, with an EV/FCF ratio of 29.73.
| EV / Earnings | n/a |
| EV / Sales | 1.66 |
| EV / EBITDA | 8.63 |
| EV / EBIT | 11.89 |
| EV / FCF | 29.73 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.95 |
| Quick Ratio | 1.44 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 5.51 |
| Debt / FCF | 21.68 |
| Interest Coverage | 1.60 |
Financial Efficiency
Return on equity (ROE) is 2.32% and return on invested capital (ROIC) is 5.12%.
| Return on Equity (ROE) | 2.32% |
| Return on Assets (ROA) | 3.66% |
| Return on Invested Capital (ROIC) | 5.12% |
| Return on Capital Employed (ROCE) | 6.28% |
| Weighted Average Cost of Capital (WACC) | 8.45% |
| Revenue Per Employee | $210,394 |
| Profits Per Employee | -$5,538 |
| Employee Count | 16,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 28.03 |
Taxes
In the past 12 months, SGRY has paid $20.50 million in taxes.
| Income Tax | 20.50M |
| Effective Tax Rate | 20.02% |
Stock Price Statistics
The stock price has decreased by -37.13% in the last 52 weeks. The beta is 1.91, so SGRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.91 |
| 52-Week Price Change | -37.13% |
| 50-Day Moving Average | 14.53 |
| 200-Day Moving Average | 14.52 |
| Relative Strength Index (RSI) | 42.78 |
| Average Volume (20 Days) | 2,330,286 |
Short Selling Information
The latest short interest is 13.29 million, so 10.25% of the outstanding shares have been sold short.
| Short Interest | 13.29M |
| Short Previous Month | 12.95M |
| Short % of Shares Out | 10.25% |
| Short % of Float | 20.20% |
| Short Ratio (days to cover) | 5.30 |
Income Statement
In the last 12 months, SGRY had revenue of $3.37 billion and -$88.60 million in losses. Loss per share was -$0.69.
| Revenue | 3.37B |
| Gross Profit | 757.90M |
| Operating Income | 469.20M |
| Pretax Income | 102.40M |
| Net Income | -88.60M |
| EBITDA | 646.40M |
| EBIT | 469.20M |
| Loss Per Share | -$0.69 |
Balance Sheet
The company has $216.70 million in cash and $4.07 billion in debt, with a net cash position of -$3.85 billion or -$29.68 per share.
| Cash & Cash Equivalents | 216.70M |
| Total Debt | 4.07B |
| Net Cash | -3.85B |
| Net Cash Per Share | -$29.68 |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 12.88 |
| Working Capital | 547.50M |
Cash Flow
In the last 12 months, operating cash flow was $258.00 million and capital expenditures -$70.40 million, giving a free cash flow of $187.60 million.
| Operating Cash Flow | 258.00M |
| Capital Expenditures | -70.40M |
| Depreciation & Amortization | 177.20M |
| Net Borrowing | 119.80M |
| Free Cash Flow | 187.60M |
| FCF Per Share | $1.45 |
Margins
Gross margin is 22.51%, with operating and profit margins of 13.94% and -2.63%.
| Gross Margin | 22.51% |
| Operating Margin | 13.94% |
| Pretax Margin | 3.04% |
| Profit Margin | -2.63% |
| EBITDA Margin | 19.20% |
| EBIT Margin | 13.94% |
| FCF Margin | 5.57% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.28% |
| Shareholder Yield | -1.28% |
| Earnings Yield | -5.13% |
| FCF Yield | 10.86% |
Analyst Forecast
The average price target for SGRY is $18.82, which is 41.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.82 |
| Price Target Difference | 41.29% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -2.02% |
| EPS Growth Forecast (3Y) | -5.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 0.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 5 |